Journal
CLINICAL INFECTIOUS DISEASES
Volume 66, Issue 5, Pages 778-788Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cix881
Keywords
metagenomics; diagnosis; next-generation sequencing; bioinformatics
Categories
Funding
- Accelerate Diagnostics
- Curetis
- BD Diagnostics
- GenePOC
- Roche Molecular
- McGraw-Hill
- American Society for Microbiology
- Elsevier
- bioMerieux
- Cellex
- Check-Points Diagnostics
- BV
- Hardy Diagnostics
Ask authors/readers for more resources
Agnostic metagenomic next-generation sequencing (mNGS) has emerged as a promising single, universal pathogen detection method for infectious disease diagnostics. This methodology allows for identification and genomic characterization of bacteria, fungi, parasites, and viruses without the need for a priori knowledge of a specific pathogen directly from clinical specimens. Although there are increasing reports of mNGS successes, several hurdles need to be addressed, such as differentiation of colonization from infection, extraneous sources of nucleic acid, method standardization, and data storage, protection, analysis, and interpretation. As more commercial and clinical microbiology laboratories develop mNGS assays, it is important for treating practitioners to understand both the power and limitations of this method as a diagnostic tool for infectious diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available